182 related articles for article (PubMed ID: 11583677)
1. Subclassification of preproliferative diabetic retinopathy and glycemic control: relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy.
Sato Y; Lee Z; Hayashi Y
Jpn J Ophthalmol; 2001; 45(5):523-7. PubMed ID: 11583677
[TBL] [Abstract][Full Text] [Related]
2. [Preproliferative diabetic retinopathy sub-classification and glycemic control--relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy].
Sato Y; Lee Z; Hayashi Y
Nippon Ganka Gakkai Zasshi; 2001 May; 105(5):322-5. PubMed ID: 11406948
[TBL] [Abstract][Full Text] [Related]
3. The subclassification and long-term prognosis of preproliferative diabetic retinopathy.
Sato Y; Lee Z
Jpn J Ophthalmol; 2002; 46(3):323-9. PubMed ID: 12063044
[TBL] [Abstract][Full Text] [Related]
4. Early risk stratification in pediatric type 1 diabetes.
Broe R
Acta Ophthalmol; 2015 Mar; 93 Thesis 1():1-19. PubMed ID: 25703648
[TBL] [Abstract][Full Text] [Related]
5. [The sub-classification and long-term prognosis of preproliferative diabetic retinopathy].
Sato Y; Lee Z
Nippon Ganka Gakkai Zasshi; 2001 Jun; 105(6):394-8. PubMed ID: 11449689
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Risk for Developing Proliferative Diabetic Retinopathy after Photocoagulation for Diabetic Maculopathy.
Bek T
Curr Eye Res; 2020 Aug; 45(8):986-991. PubMed ID: 31920110
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial.
Mirshahi A; Roohipoor R; Lashay A; Mohammadi SF; Abdoallahi A; Faghihi H
Eur J Ophthalmol; 2008; 18(2):263-9. PubMed ID: 18320520
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Haplogroups Modify the Effect of Diabetes Duration and HbA1c on Proliferative Diabetic Retinopathy Risk in Patients With Type 2 Diabetes.
Mitchell SL; Neininger AC; Bruce CN; Chocron IM; Bregman JA; Estopinal CB; Muhammad A; Umfress AC; Jarrell KL; Warden C; Harlow PA; Wellons M; Samuels DC; Brantley MA
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6481-6488. PubMed ID: 29288266
[TBL] [Abstract][Full Text] [Related]
9. Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy.
; Sato Y; Kojimahara N; Kitano S; Kato S; Ando N; Yamaguchi N; Hori S
Jpn J Ophthalmol; 2012 Jan; 56(1):52-9. PubMed ID: 22009219
[TBL] [Abstract][Full Text] [Related]
10. Systemic association of newly diagnosed proliferative diabetic retinopathy among type 2 diabetes patients presented at a tertiary eye hospital of Nepal.
Thapa R; Bajimaya S; Sharma S; Rai BB; Paudyal G
Nepal J Ophthalmol; 2015; 7(1):26-32. PubMed ID: 26695602
[TBL] [Abstract][Full Text] [Related]
11. Glycemic control and the risk of multiple microvascular diabetic complications.
Schellhase KG; Koepsell TD; Weiss NS
Fam Med; 2005 Feb; 37(2):125-30. PubMed ID: 15690253
[TBL] [Abstract][Full Text] [Related]
12. Early increase in HbA1c trajectory predicts development of severe microangiopathy in patients with type 1 diabetes: the VISS study.
Arnqvist HJ; Ludvigsson J; Nordwall M
BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719508
[TBL] [Abstract][Full Text] [Related]
13. Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up.
Chen MS; Kao CS; Fu CC; Chen CJ; Tai TY
Int J Epidemiol; 1995 Aug; 24(4):787-95. PubMed ID: 8550277
[TBL] [Abstract][Full Text] [Related]
14. Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy.
Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
Acta Ophthalmol; 2013 May; 91(3):251-8. PubMed ID: 22176513
[TBL] [Abstract][Full Text] [Related]
15. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England.
Jones CD; Greenwood RH; Misra A; Bachmann MO
Diabetes Care; 2012 Mar; 35(3):592-6. PubMed ID: 22279031
[TBL] [Abstract][Full Text] [Related]
16. The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients.
Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
Diabetes Res Clin Pract; 2011 Feb; 91(2):e40-2. PubMed ID: 21035886
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal intermittent serious hypoxia and reoxygenation in proliferative diabetic retinopathy cases.
Shiba T; Maeno T; Saishin Y; Hori Y; Takahashi M
Am J Ophthalmol; 2010 Jun; 149(6):959-63. PubMed ID: 20381785
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic alterations in diabetic retinopathy.
Güven D; Ozdemir H; Hasanreisoglu B
Ophthalmology; 1996 Aug; 103(8):1245-9. PubMed ID: 8764795
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
Davis MD; Fisher MR; Gangnon RE; Barton F; Aiello LM; Chew EY; Ferris FL; Knatterud GL
Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):233-52. PubMed ID: 9477980
[TBL] [Abstract][Full Text] [Related]
20. Retinal main vessel calibers and systemic markers for long-term development of proliferative diabetic retinopathy.
Dinesen S; Stokholm L; Subhi Y; Henriksen JE; Savarimuthu TR; Peto T; Grauslund J
Acta Ophthalmol; 2024 Jun; 102(4):448-454. PubMed ID: 37803999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
